{"id":"https://openalex.org/W47495389","doi":null,"title":"[Clinical problems in gemcitabine treatment for unresectable pancreatic cancer in the elderly--a multicentric retrospective study of 53 cases].","display_name":"[Clinical problems in gemcitabine treatment for unresectable pancreatic cancer in the elderly--a multicentric retrospective study of 53 cases].","publication_year":2004,"publication_date":"2004-11-01","ids":{"openalex":"https://openalex.org/W47495389","mag":"47495389","pmid":"https://pubmed.ncbi.nlm.nih.gov/15570926"},"language":"ja","primary_location":{"id":"pmid:15570926","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15570926","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"English Abstract"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004533665","display_name":"Nobumichi Takeuchi","orcid":"https://orcid.org/0000-0001-9953-785X","observed_orcids":["https://orcid.org/0000-0001-9953-785X"]},"institutions":[{"id":"https://openalex.org/I4405255803","display_name":"INA Central Hospital","ror":"https://ror.org/03ejtwf02","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405255803"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Nobumichi Takeuchi","raw_affiliation_strings":["Dept of Surgery, Ina Central Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Surgery, Ina Central Hospital","institution_ids":["https://openalex.org/I4405255803"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000237159","display_name":"Shinya Maejima","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shinya Maejima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022028123","display_name":"Osamu Hasebe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Osamu Hasebe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041768674","display_name":"Yoshiaki Matsuda","orcid":"https://orcid.org/0000-0002-7875-2670","observed_orcids":["https://orcid.org/0000-0002-7875-2670"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yoshiaki Matsuda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055865253","display_name":"Kazuhiro Hanazaki","orcid":"https://orcid.org/0000-0001-7986-6146","observed_orcids":["https://orcid.org/0000-0001-7986-6146"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kazuhiro Hanazaki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109842681","display_name":"Shoji Kajikawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shoji Kajikawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012284578","display_name":"Kenji Mukawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenji Mukawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108222122","display_name":"Koichi Hosokawa","orcid":"https://orcid.org/0009-0009-4358-3705","observed_orcids":["https://orcid.org/0009-0009-4358-3705"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Koichi Hosokawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058567411","display_name":"Ken Hayashi","orcid":"https://orcid.org/0000-0002-7297-1477","observed_orcids":["https://orcid.org/0000-0002-7297-1477"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ken Hayashi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063929993","display_name":"Takeshi Hisa","orcid":"https://orcid.org/0000-0002-8220-7595","observed_orcids":["https://orcid.org/0000-0002-8220-7595"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takeshi Hisa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036220184","display_name":"Kiyoshi Furut","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kiyoshi Furut","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052328151","display_name":"Kazuo Tajiri","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kazuo Tajiri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066810294","display_name":"Yoshiro Fujimori","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yoshiro Fujimori","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112069458","display_name":"Gengo Kaneko","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gengo Kaneko","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008391099","display_name":"Yasuhide Ochi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yasuhide Ochi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103923581","display_name":"Naoto Shikama","orcid":"https://orcid.org/0000-0001-7066-0010","observed_orcids":["https://orcid.org/0000-0001-7066-0010"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naoto Shikama","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101703284","display_name":"Shigeyuki Kawa","orcid":"https://orcid.org/0000-0001-7870-9149","observed_orcids":["https://orcid.org/0000-0001-7870-9149"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shigeyuki Kawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073399947","display_name":"Shinichi Miyagawa","orcid":"https://orcid.org/0000-0003-1360-6215","observed_orcids":["https://orcid.org/0000-0003-1360-6215"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shinichi Miyagawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Shiro Miwa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shiro Miwa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109148063","display_name":"Kendo Kiyosawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kendo Kiyosawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1838,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.56281553,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"12","first_page":"1987","last_page":"91"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10760","display_name":"Pancreatitis Pathology and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/unresectable-pancreatic-cancer","display_name":"unresectable pancreatic cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.9980000257492065},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.6970000267028809},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.7960000038146973},{"id":"https://openalex.org/keywords/non-hematologic-toxicity","display_name":"non-hematologic toxicity","score":0.8830000162124634},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.6320000290870667},{"id":"https://openalex.org/keywords/administration-schedule","display_name":"administration schedule","score":0.7860000133514404},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.6959999799728394}],"concepts":[{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.9661867618560791},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8338478803634644},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.8325307369232178},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.7634578943252563},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5930726528167725},{"id":"https://openalex.org/C68387754","wikidata":"https://www.wikidata.org/wiki/Q7271585","display_name":"Schedule","level":2,"score":0.49036097526550293},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.45676350593566895},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4485430419445038},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.38965246081352234},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:15570926","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15570926","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"English Abstract"},{"id":"mag:47495389","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15570926","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2416399209","https://openalex.org/W2064894357","https://openalex.org/W2293330420","https://openalex.org/W2039360554","https://openalex.org/W2217975404","https://openalex.org/W2588537701","https://openalex.org/W2001891495","https://openalex.org/W2049104483","https://openalex.org/W2913277547","https://openalex.org/W3036882192"],"abstract_inverted_index":{"In":[0],"Gemcitabine":[1,55,110],"treatment,":[2],"elderly":[3,27,67],"patients":[4,28,68,119],"with":[5],"unresectable":[6,116],"pancreatic":[7,117],"cancer":[8,118],"are":[9],"more":[10],"likely":[11],"to":[12,36,57],"suffer":[13],"from":[14,31,88],"haematological":[15],"and":[16,61],"non-haematological":[17,43],"adverse":[18,38,49,94],"effects":[19],"than":[20],"non-elderly":[21],"patients.":[22],"Forty":[23],"percent":[24],"of":[25,42,71,101],"the":[26,32,37,51,72,79,99,109],"were":[29],"dropped":[30],"initial":[33],"protocol":[34],"due":[35],"effects,":[39,50],"mainly":[40],"because":[41],"events":[44],"or":[45],"symptoms.":[46],"To":[47],"avoid":[48],"administration":[52,90,103],"schedule":[53,91,104],"for":[54,66],"tended":[56],"be":[58,106,113],"less":[59],"often":[60],"at":[62],"a":[63,85],"lower":[64],"dose":[65,111],"among":[69],"members":[70],"Nagano":[73],"Pancreatic":[74],"Cancer":[75],"Study":[76],"Group.":[77],"However,":[78],"fact":[80],"that":[81,98],"some":[82],"cases":[83],"showed":[84],"limited":[86],"effect":[87],"this":[89],"albeit":[92],"without":[93],"effect,":[95],"might":[96],"suggest":[97],"frequency":[100],"ordinary":[102],"should":[105],"maintained,":[107],"although":[108],"could":[112],"decreased":[114],"in":[115,120],"poor":[121],"condition.":[122]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2016-06-24T00:00:00"}